Project Grant H8E38873

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...

This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...

This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...

The National Science Foundation awarded a $220,000 Project Grant to the University of Connecticut under the Engineering (47.041) federal grant program. The award will fund development of a compact, field-portable biophotonics instrument for automated analysis and identification of blood cells impacted by COVID-19. The instrument aims to provide real-time sensing and diagnosis capabilities with high accuracy, specificity and sensitivity for potential early detection of COVID-19 infections. It...

Federal Cooperative Agreement Summary The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) awarded the Association of Public Health Laboratories, Inc. (APHL) a $6.98 million Cooperative Agreement under the Emerging Infections Programs (EIP, CFDA 93.317) to enhance public health laboratory capabilities and capacities from July 1, 2025, through June 30, 2030. This five-year award supports APHL's mission to strengthen laboratory infrastructure, surveillance systems, and...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

DPX Technologies LLC received a $254,536 Project Grant award from the National Science Foundation to develop high-throughput COVID-19 testing under the SBIR PHASE I program. The award, provided by NSF's Directorate for Engineering between April 1, 2021 and September 30, 2021, aims to foster innovation in engineering research and development under the Engineering (47.041) federal grant program. Specifically, DPX Technologies will leverage the funding to create products and services focused on...

This $200,000 project grant from the National Science Foundation's Computer and Information Science and Engineering program will fund research at the University of California, Berkeley to develop group testing methods for infectious disease monitoring and mitigation. Specifically, the grant supports the creation of specialized machine learning, combinatorial, and information-theoretic techniques to (1) identify low-mutation genomic regions for polymerase chain reaction (PCR) primers, (2) model...

Federal Grant Award Summary Pace Diagnostics, Inc. received a $600,000 Project Grant from the Centers for Disease Control and Prevention (CDC) Office of the Director under the CDC Investigations and Technical Assistance program (CFDA 93.283) for the development and delivery of an ultrasensitive urine tuberculosis (TB) antigen rapid detection test. The award, effective September 30, 2025, with a completion date of March 31, 2026, supports the creation of an innovative diagnostic technology...

This National Science Foundation Technology, Innovation, and Partnerships Project Grant totaling $265,999 will support Rutgers, The State University of New Jersey, Camden in developing a rapid and reliable point-of-care screening for infectious diseases such as COVID-19. Specifically, the university will demonstrate a mass screening method to rapidly detect viruses to identify early infected individuals for quarantine. This work will enable rapid and reliable point-of-care detection with...